Rankings
▼
Calendar
VRCA Q1 2023 Earnings — Verrica Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena
VRCA
Verrica Pharmaceuticals Inc.
$56M
Q1 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$37,000
-91.4% YoY
Gross Profit
-$31,000
-83.8% margin
Operating Income
-$7M
-19159.5% margin
Net Income
-$7M
-17808.1% margin
EPS (Diluted)
$-1.53
QoQ Revenue Growth
-45.6%
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$5M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$69M
Total Liabilities
$4M
Stockholders' Equity
$65M
Cash & Equivalents
$60M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$37,000
$431,000
-91.4%
Gross Profit
-$31,000
$153,000
-120.3%
Operating Income
-$7M
-$7M
+4.3%
Net Income
-$7M
-$8M
+22.2%
← FY 2023
All Quarters
Q2 2023 →